About Transcenta Therapeutics Transcenta (HKEX: 06628) is a global clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, ...

The 2025 Directions overhaul asset liability management norms for AIFIs with clear Board and ALCO accountability. The key takeaway is tighter control over liquidity gaps and interest rate exposure ...

(Yicai) Dec. 29 -- Shanghai is seeing the emergence of a new professional group of so-called “scientist partners,” or ...

The report highlights that there are a few key enablers of growth that uniquely strengthen India’s position in the global ...